An artificial protein-cage comprising encapsulated therein a guest cargo
OwnerJonathan HEDDLE, Artur BIELA +5inventors
InventorsJonathan HEDDLE, Artur BIELA, Yusuke AZUMA, Antonina NASKALSKA, Kinga BORZECKA-SOLARZ, Jan ROZYCKI, Izabela STUPKA
Life of this patent
Estimating the term…
Abstract
The present invention provides an artificial TRAP-cage comprising a selected number of TRAP rings and encapsulated therein a guest cargo.
Claims42
An artificial TRAP-cage comprising a selected number of TRAP rings and encapsulated therein at least one guest cargo.
The cage according to any preceding claim, wherein the guest cargo is a protein and preferably the protein is a fluorescent protein, interleukin-2 (IL-2) or Neoleukin-2/15 (NL-2).
The cage according to any preceding claim, further including at least one external decoration.
The cage according to any preceding claim, wherein the number of TRAP rings in the TRAP-cage is between 6 to 60.
The cage according to any preceding claim, wherein the interior surface of the TRAP-cage lumen is supercharged and the TRAP-cage protein comprises a E48Q or a E48K mutation.
The cage according to any preceding claim, wherein the artificial TRAP-cage protein is modified to comprise any one or more of the following mutations selected from the group comprising, comprising K35C, K35H, R64S, E48Q, E48K, K35C/R64S, K35H/R64S, S33C, S33H, S33C/R64S, S33H/R64S, S33C/K35H S33H/K35H, S33C/K35C, S33H/K35C, K35C/E48Q, K35C/E48K, K35H/E48Q, K35H/E48K, S33C/E48Q, S33C/E48K, S33C/E48Q and S33C/E48K.
The TRAP-cage according to any preceding claim, wherein opening of the cage is programmable.
Use of the artificial TRAP-cage according to any preceding claim as a delivery vehicle for intracellular delivery of its internal guest cargo.
A method of making an artificial TRAP-cage with an encapsulated guest cargo, the method comprising:
- (i) obtaining TRAP ring units by expression of the TRAP ring units in a suitable expression system and purification of the said units from the expression system;
- (ii) conjugation of the TRAP ring units via at least one free thiol linkage with a cross-linker;
- (iii) modification of the TRAP ring units to provide a suitable interior surface environment for capturing a guest cargo;
- (iv) formation of the TRAP-cage by self-assembly to provide a cage lumen wherein the guest cargo is encapsulated;
- and
- (v) purification and isolation of the TRAP-cages encapsulating the guest cargo.
An artificial TRAP-cage protein modified to comprise any one or more of the following mutations selected from the group comprising K35C, K35H, R64S, E48Q, E48K, K35C/R64S, K35H/R64S, S33C, S33H, S33C/R64S, S33H/R64S, S33C/K35H S33H/K35H, S33C/K35C, S33H/K35C, K35C/E48Q, K35C/E48K, K35H/E48Q, K35H/E48K, S33C/E48Q, S33C/E48K, S33C/E48Q and S33C/E48K.
A method of treatment of an individual in need of therapy suffering from a condition selected from the group comprising cancer, vascular disease, cardiovascular disease, diabetes, infection, auto-immune condition, neurodegenerative and neurological disease, cellular senescence disease, arthritis and respiratory disease, the method comprising administering a therapeutically effective amount of an artificial TRAP-cage bearing one or more internal guest cargo selected from the group comprising a nucleic acid, an enzyme, a therapeutic agent, a small molecule, organic or inorganic nanoparticles, a peptide, a metal, an antigen, an antibody and toxin and fragments thereof of all the foregoing that are of therapeutic value.
A method of vaccinating an individual in need of vaccination from a condition selected from the group comprising cancer, vascular disease, cardiovascular disease, diabetes, infection, auto-immune condition, neurodegenerative and neurological disease, cellular senescence disease, arthritis and respiratory disease, the method comprising administering a therapeutically effective amount of an artificial TRAP-cage bearing one or more internal guest cargo selected from the group comprising a nucleic acid, an enzyme, a therapeutic agent, a small molecule, organic or inorganic nanoparticles, a peptide, a metal, an antigen, an antibody and toxin and fragments thereof of all the foregoing that are of therapeutic value
Dependencies are inferred from the claim text.